Publicaciones (59) Publicaciones en las que ha participado algún/a investigador/a

2014

  1. Active hexose correlated compound exerts therapeutic effects in lymphocyte driven colitis

    Molecular Nutrition and Food Research, Vol. 58, Núm. 12, pp. 2379-2382

  2. Actividad de albendazol y los aceites esenciales de menta (Mentha piperita) y manzanilla (Matricaria chamomilla) frente Anisakis tipo I

    Ars pharmaceutica, Vol. 55, Núm. 1, pp. 45-49

  3. Activity of melatonin against Leishmania infantum promastigotes by mitochondrial dependent pathway

    Chemico-Biological Interactions, Vol. 220, pp. 84-93

  4. Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: An uncontrolled, 12-week, pilot study

    Pharmacopsychiatry, Vol. 47, Núm. 2, pp. 67-72

  5. Bupivacaine-induced cellular entry of QX-314 and its contribution to differential nerve block

    British Journal of Pharmacology, Vol. 171, Núm. 2, pp. 438-451

  6. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus

    Hypertension, Vol. 64, Núm. 2, pp. 330-337

  7. Current status of atypical antipsychotics for the treatment of fibromyalgia

    Drugs of Today, Vol. 50, Núm. 6, pp. 435-444

  8. Diagnosis of leishmaniasis

    Journal of Infection in Developing Countries, Vol. 8, Núm. 8, pp. 961-972

  9. Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population

    European Journal of Pain (United Kingdom), Vol. 18, Núm. 1, pp. 101-109

  10. Diminished Schwann cell repair responses underlie age-associated impaired axonal regeneration

    Neuron, Vol. 83, Núm. 2, pp. 331-343

  11. Drug assessment by a Pharmacy and Therapeutics committee: From drug selection criteria to use in clinical practice

    Therapeutics and Clinical Risk Management, Vol. 10, Núm. 1, pp. 527-535

  12. Efectos de un programa de Atención Farmacéutica para pacientes con esclerosis múltiple sobre la adherencia al tratamiento inmunomodulador

    Ars pharmaceutica, Vol. 55, Núm. 1, pp. 37-44

  13. Effect of a school-intervention in a health related parameter on children

    Handbook of Physical Education Research: Role of School Programs, Children's Attitudes and Health Implications (Nova Science Publishers, Inc.), pp. 283-296

  14. Effects of factor Xa on the expression of proteins in femoral arteries from type 2 diabetic patients

    British Journal of Clinical Pharmacology, Vol. 78, Núm. 6, pp. 1366-1377

  15. Exposure to bis(maltolato)oxovanadium(IV) increases levels of hepcidin mRNA and impairs the homeostasis of iron but not that of manganese

    Food and Chemical Toxicology, Vol. 73, pp. 113-118

  16. Fibromyalgia: Comorbidity indicative of vulnerability?

    Medicina Clinica, Vol. 142, Núm. 12, pp. 538-539

  17. Food derived bioactive peptides and intestinal barrier function

    International Journal of Molecular Sciences, Vol. 15, Núm. 12, pp. 22857-22873

  18. Fructooligosacharides reduce Pseudomonas aeruginosa PAO1 pathogenicity through distinct mechanisms

    PLoS ONE, Vol. 9, Núm. 1

  19. Fármacos antianginosos

    Farmacología humana (Elsevier), pp. 651-661

  20. Genetic deletion of aquaporin-1 results in microcardia and low blood pressure in mouse with intact nitric oxide-dependent relaxation, but enhanced prostanoids-dependent relaxation

    Pflugers Archiv European Journal of Physiology, Vol. 466, Núm. 2, pp. 237-251